References
- Gunnell D, Eddleston M, Phillips MR, Konradsen F. The global distribution of fatal pesticide self-poisoning: systematic review. BMC Public Health 2007; 7:357.
- Marrs TC. Toxicology of organophosphate nerve agents. In: Marrs TC, Maynard RL, Sidell FR, eds.Chemical Warfare Agents: Toxicology and Treatment. Chichester, West Sussex: John Wiley & Sons Ltd.; 2007:191–221.
- Bryant PJR, Ford-Moore AH, Perry BJ, Wardrop AWH, Watkins TF. The preparation and physical properties of isopropyl methylphosphonofluoridate (Sarin).J Chem Soc 1960:1553–1555.
- Holmstedt B. Pharmacology of organophosphorus cholinesterase inhibitors. Pharmacol Rev 1959; 11:567–688.
- Aldridge WN, Reiner E. Enzyme Inhibitors as Substrates – Interactions of Esterases with Esters of Organophosphorus and Carbamic Acids. Amsterdam: North-Holland Publishing Company; 1972.
- Taylor P, Radic Z, Hosea NA, Camp S, Marchot P, Berman HA. Structural bases for the specificity of cholinesterase catalysis and inhibition. Toxicol Lett 1995; 82–83:453–458.
- Grob D. The manifestations and treatment of poisoning due to nerve gas and other organic phosphate anticholinesterase compounds. AMA Arch Intern Med 1956; 98:221–239.
- Kwong TC. Organophosphate pesticides: biochemistry and clinical toxicology. Ther Drug Monit 2002; 24:144–149.
- Lee EC. Clinical manifestations of sarin nerve gas exposure. JAMA 2003; 290:659–662.
- Eyer F, Worek F, Eyer P, Felgenhauer N, Haberkorn M, Zilker T, Thiermann H. Obidoxime in acute organophosphate poisoning. 1: clinical effectiveness. Clin Toxicol 2009; 47:798–806.
- Jokanovic M, Prostran M. Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr Med Chem 2009; 16:2177–2188.
- Worek F, Thiermann H. The value of novel oximes for treatment of poisoning by organophosphorus compounds. Pharmacol Ther 2013; 139:249–259.
- Masson P, Rochu D. Catalytic bioscavengers: the next generation of bioscavenger-based medical countermeasures. In: Gupta R, ed. Handbook of Toxicology of Chemical Warfare Agents. London: Academic Press; 2009:1053–1065.
- Nachon F, Brazzolotto X, Trovaslet M, Masson P. Progress in the development of enzyme-based nerve agent bioscavengers. Chem Biol Interact 2013; doi: 10.1016/j.cbi.2013.06.012.
- Wille T, Tenberken O, Reiter G, Müller S, Le Provost R, Lafont O, et al. Detoxification of nerve agents by a substituted beta- cyclodextrin: application of a modified biological assay. Toxicology 2009; 265:96–100.
- van Hooidonk C, Breebaart-Hansen JC. Stereospecific reaction of isopropyl methyl-phosphonofluoridate (sarin) with alpha-cyclodextrin. Recueil 1970; 89:289–299.
- Jamaty C, Bailey B, Larocque A, Notebaert E, Sanogo K, Chauny JM. Lipid emulsions in the treatment of acute poisoning: a systematic review of human and animal studies. Clin Toxicol 2010; 48:1–27.
- Ozcan MS, Weinberg G. Intravenous lipid emulsion for the treatment of drug toxicity. J Intensive Care Med 2012; doi: 10.1177/0885066612445978.
- Turner-Lawrence DE, Kerns W. Intravenous fat emulsion: a potential novel antidote. J Med Toxicol 2008; 4:109–114.
- Bania TC, Chu J, Stolbach A. The effect of intralipid on organophosphate toxicity in mice. Acad Emerg Med 2005; 12:12.
- Dunn C, Bird SB, Gaspari R. Intralipid fat emulsion decreases respiratory failure in a rat model of parathion exposure. Acad Emerg Med 2012; 19:504–509.
- Worek F, Mast U, Kiderlen D, Diepold C, Eyer P. Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 1999; 288:73–90.
- Aurbek N, Thiermann H, Szinicz L, Eyer P, Worek F. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase. Toxicology 2006; 224:91–99.
- Müller S, Koller M, Le Provost R, Lafont O, Estour F, Wille T, et al. In vitro detoxification of cyclosarin (GF) by modified cyclodextrins. Toxicol Lett 2011; 200:53–58.
- Estour F, Letort S, Müller S, Kalakuntla RK, Le Provost R, Wille T, et al. Functionalized cyclodextrins bearing an alpha nucleophile - a promising way to degrade nerve agents. Chem Biol Interact 2013; 203:202–207.
- Adam JM, Bennett DJ, Bom A, Clark JK, Feilden H, Hutchinson EJ, et al. Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. J Med Chem 2002; 45:1806–1816.
- Cave G, Harvey M. Intravenous lipid emulsion as antidote beyond local anesthetic toxicity: a systematic review. Acad Emerg Med 2009; 16:815–824.
- Zhou Y, Zhan C, Li Y, Zhong Q, Pan H, Yang G. Intravenous lipid emulsions combine extracorporeal blood purification: a novel therapeutic strategy for severe organophosphate poisoning. Med Hypotheses 2010; 74:309–311.
- Perichon D, Turfus S, Gerostamoulos D, Graudins A. An assessment of the in vivo effects of intravenous lipid emulsion on blood drug concentration and haemodynamics following oro-gastric amitriptyline overdose. Clin Toxicol (Phila) 2013; 51:208–215.
- Litonius E, Niiya T, Neuvonen PJ, Rosenberg PH. No antidotal effect of intravenous lipid emulsion in experimental amitriptyline intoxication despite significant entrapment of amitriptyline. Basic Clin Pharmacol Toxicol 2012; 110:378–383.
- Van de Velde M, Wouters PF, Rolf N, Van Aken H, Flameng W, Vandermeersch E. Long-chain triglycerides improve recovery from myocardial stunning in conscious dogs. Cardiovasc Res 1996; 32:1008–1015.
- Stehr SN, Ziegeler JC, Pexa A, Oertel R, Deussen A, Koch T, Hübler M. The effects of lipid infusion on myocardial function and bioenergetics in l-bupivacaine toxicity in the isolated rat heart. Anesth Analg 2007; 104:186–192.
- Huang JM, Xian H, Bacaner M. Long-chain fatty acids activate calcium channels in ventricular myocytes. Proc Natl Acad Sci USA 1992; 89:6452–6456.